Day One Biopharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers.
Day One Biopharmaceuticals stock last closed at $7.51, down 1.05% from the previous day, and has decreased 45.06% in one year. It has overperformed other stocks in the Biotechnology industry by 0.08 percentage points. Day One Biopharmaceuticals stock is currently +33.27% from its 52-week low of $5.64, and -55.19% from its 52-week high of $16.76.
As of Aug 29, 2025, there are 102.43M shares of DAWN outstanding. The market value of DAWN is $769.26M. In the last 24 hours, 894,000 DAWN shares were traded.
How to Buy Day One Biopharmaceuticals Stock
Wondering how to invest in Day One Biopharmaceuticals stock? Here's how.
Decide where to buy Day One Biopharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Day One Biopharmaceuticals stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your investment account: Select your payment method and add your details.
Analyze Day One Biopharmaceuticals stock: The Day One Biopharmaceuticals ticker symbol is DAWN. Is Day One Biopharmaceuticals stock a good investment? Should you buy shares of DAWN? How do DAWN's underlying business fundamentals look? Do top analysts think Day One Biopharmaceuticals is a good buy? Why has DAWN's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if DAWN is a good stock to buy).
Place your DAWN trade: Decide if you will purchase DAWN shares at the current market price or use a limit order to purchase DAWN shares at a specific price.
Monitor your investment in DAWN: Create a watchlist to important updates regarding your investment in Day One Biopharmaceuticals shares.
Step 1: Decide where to buy Day One Biopharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy DAWN stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal details so you are able to invest in DAWN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Day One Biopharmaceuticals stock
After you have chosen the best place to buy Day One Biopharmaceuticals stock, it's important to research their stock before you invest, so you truly understand the risk as well as the upside.
Day One Biopharmaceuticals quick stats
DAWN Price
$7.51
1w %
4.31%
1y %
-45.06%
5y %
N/A
P/E
-7.91x
P/B
1.67x
P/S
4.12x
PEG
N/A
Revenue
$187.64M
Earnings
-$95.00M
Fore. Rev. Growth
14.89%
Fore. Earn. Growth
N/A
Market Cap
$769.26M
Next Earnings
N/A
Next Dividend
N/A
Day One Biopharmaceuticals Fundamentals
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis quickly.
Last year, DAWN revenue was $187.64M. During the last 1 years, DAWN's revenue has gone up by 2,190.5% per year. This was faster than the Biotechnology industry average of 67.2%.
No, Day One Biopharmaceuticals doesn't provide an income stream by paying out dividends.
DAWN Social Trading Data
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your DAWN trade
There are two main types of orders:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are usually sufficient.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a particular dollar amount limit, place a limit order.
Press the Open button and your broker will execute your order.
If you want more assistance investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Day One Biopharmaceuticals share?
As of Aug 29, 2025, it costs $7.51 to buy one share of Day One Biopharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.399 shares of DAWN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.